AD

Anirudha Das

Active Director Managing Director DIN 10184104
DIN 10184104 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Anirudha Das

Data last updated:

Anirudha Das is a Managing Director at Curaplus Life Sciences Private Limited (since 2023). Curaplus Life Sciences Private Limited reported revenue of ₹92,798 (FY 2025).

DIN 10184104
Primary Designation Managing Director
First Appointment 30 May 2023
Oldest Company Age 3 yrs
Largest company Curaplus Life Sciences Private Limited · ₹92,798 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director30 May 20232023₹92,798 (FY 2025)Active

Board colleagues of Anirudha Das

NameDINCompanyDesignation
Anusaya Das10184103Curaplus Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curaplus Life Sciences Private Limited
Premium access

Shareholding and investment profile for Anirudha Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anirudha Das

Anirudha Das currently holds 1 directorship: Curaplus Life Sciences Private Limited (Managing Director, since 30 May 2023, revenue ₹92,798 (FY 2025)).

Anirudha Das was first appointed on 30 May 2023 as Managing Director at Curaplus Life Sciences Private Limited.

The current boards of Anirudha Das's companies include Anusaya Das (Curaplus Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available